Earkart Limited
Earkart Manufacture and distribute modern hearing aids and related accessories at affordable price across India. Along with our own manufactured hearing aid, we also trade in hearing aid, parts and accessories of other brands manufactured in India and abroad.(Source : 202509 Prospectus Page No: 20)
- Market Cap ₹ 219 Cr.
- Current Price ₹ 160
- High / Low ₹ 266 / 136
- Stock P/E 40.5
- Book Value ₹
- Dividend Yield 0.00 %
- ROCE 45.1 %
- ROE 41.8 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Company has a good return on equity (ROE) track record: 3 Years ROE 35.3%
Cons
- Company has high debtors of 157 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Equipment & Supplies Medical Equipment & Supplies
Part of BSE SME IPO
Half Yearly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| 5.66 | 28.92 | 31.75 | 43.11 | |
| 5.52 | 27.29 | 28.17 | 33.32 | |
| Operating Profit | 0.14 | 1.63 | 3.58 | 9.79 |
| OPM % | 2.47% | 5.64% | 11.28% | 22.71% |
| 0.04 | 0.05 | 0.21 | 0.09 | |
| Interest | 0.01 | 0.08 | 0.36 | 0.44 |
| Depreciation | 0.06 | 0.15 | 0.19 | 0.42 |
| Profit before tax | 0.11 | 1.45 | 3.24 | 9.02 |
| Tax % | 0.00% | 9.66% | 5.86% | 23.61% |
| 0.11 | 1.31 | 3.06 | 6.88 | |
| EPS in Rs | 22.00 | 262.00 | 612.00 | 6.59 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 97% |
| TTM: | 36% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 297% |
| TTM: | 125% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 35% |
| Last Year: | 42% |
Balance Sheet
Figures in Rs. Crores
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|
| Equity Capital | 0.05 | 0.05 | 0.05 | 10.44 | 13.75 |
| Reserves | 4.72 | 6.49 | 12.97 | 9.48 | 52.31 |
| 0.27 | 1.23 | 4.02 | 4.96 | 5.62 | |
| 0.91 | 6.96 | 2.21 | 5.41 | 6.50 | |
| Total Liabilities | 5.95 | 14.73 | 19.25 | 30.29 | 78.18 |
| 0.22 | 0.25 | 1.06 | 1.17 | 1.61 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 1.46 | 0.10 | 0.19 | 0.83 | 0.83 |
| 4.27 | 14.38 | 18.00 | 28.29 | 75.74 | |
| Total Assets | 5.95 | 14.73 | 19.25 | 30.29 | 78.18 |
Cash Flows
Figures in Rs. Crores
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| -2.83 | -0.30 | -1.00 | 0.71 | |
| -1.78 | 0.40 | -1.29 | -1.32 | |
| 4.68 | 0.41 | 3.08 | -0.41 | |
| Net Cash Flow | 0.07 | 0.51 | 0.80 | -1.01 |
Ratios
Figures in Rs. Crores
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| Debtor Days | 104.47 | 59.32 | 72.89 | 157.23 |
| Inventory Days | 138.26 | 100.90 | 113.12 | 95.52 |
| Days Payable | 92.17 | 107.33 | 19.28 | 44.04 |
| Cash Conversion Cycle | 150.56 | 52.89 | 166.73 | 208.70 |
| Working Capital Days | 192.17 | 60.83 | 108.06 | 139.02 |
| ROCE % | 23.89% | 29.02% | 45.13% |
Documents
Announcements
-
Submission Of Transcript Of Valueportal Event Held On Tuesday, January 20, 2026 At 14:00 P.M.
23 Jan - Valueportal transcript (20 Jan 2026): Omni patent, FY revenue Rs43cr, 1.5 lakh units, 80 clinics, 1,500-clinic target.
-
Submission Of Voice Recording Of Valueportal Event Held On January 20, 2026.
20 Jan - Earkart virtual Valueportal investor interaction on Jan 20, 2026; general overview; no UPSI; audio posted online.
-
Intimation Regarding Bragging Govt. Orders.
14 Jan - Awarded ₹2,76,55,844 GeM government supply contract for TLM Kits to ALIMCO (one-time).
-
Intimation Regarding Bragging Govt. Orders Amounting Rs. 1.27 Crores
14 Jan - Earkart awarded ₹1,27,23,720 GeM government supply contract (TLM Kits) by ALIMCO, one-time execution.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
13 Jan - Certificate under Reg 74(5) for quarter ended 31 December 2025 from RTA.
Annual reports
No data available.
Concalls
-
Jan 2026TranscriptAI SummaryPPTREC
-
Dec 2025Transcript PPT
Business Profile[1]
Earkart manufactures and distributes modern hearing aids (BTE & RIC) and accessories, trades third-party hearing aids and parts, and also supplies mobility aids (foldable walkers) and educational/therapy kits (MSIED and TLM) for children with disabilities.